drugset / Trial / NCT00523042
Safety of Inhaled Preprandial Human Insulin in Subjects With Diabetes and Asthma
RandomizedParallel-groupOpen-labelTreatment
Summary
This trial is conducted in Europe, Asia, Oceania and the United States of America (USA). This is a one-year clinical trial to compare the safety of inhaled preprandial human insulin to subcutaneous insulin aspart in subjects with type 1 or 2 diabetes and asthma.
Timeline
- Start
- 2007-08-30
- Primary completion
- 2008-02-28
- Completion
- 2008-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin | Protein / enzyme biologic | — | Inhaled |
| Comparator | insulin aspart | Protein / enzyme biologic | — | Subcutaneous |